Tina deVries
18Patents
6h-index
5Co-inventors
59Inventor score
Filing activity: Mar 31, 2000 → May 9, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6495177B1 | Orally dissolvable nutritional supplement | Human Necessities | 64 | Expired |
| US7572779B2 | Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation | Human Necessities | 56 | Active |
| US6962908B2 | Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation | Human Necessities | 53 | Expired |
| US6521247B1 | Dual iron containing nutritional supplement | Human Necessities | 37 | Expired |
| US6667050B1 | Chewable oral contraceptive | Human Necessities | 10 | Expired |
| US7485319B2 | Doxycycline metal complex in a solid dosage form | Emerging Cross-Sectional Technologies | 7 | Expired |
| US8415331B2 | Doxycycline metal complex in a solid dosage form | Human Necessities | 3 | Active |
| US11324722B2 | Compositions and methods for treating ocular disorders | Human Necessities | 0 | Active |
| US11701343B2 | Compositions and methods for treating ocular disorders | Human Necessities | 0 | Active |
| US11311515B2 | Oxymetazoline compositions | Human Necessities | 0 | Active |
| US11103482B2 | Oxymetazoline compositions | Human Necessities | 0 | Active |
| US10898573B1 | Oxymetazoline compositions | Human Necessities | 0 | Active |
| US11219615B2 | Compositions and methods for treating ocular disorders | General | 0 | Revoked |
| US10799481B1 | Compositions and methods for treating ocular disorders | Human Necessities | 0 | Active |
| US7799771B2 | Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation | Human Necessities | 0 | Active |
| US10814001B1 | Oxymetazoline compositions | Human Necessities | 0 | Active |
| US10940138B2 | Compositions and methods for treating ocular disorders | Human Necessities | 0 | Active |
| US11541036B2 | Oxymetazoline compositions | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.